Rosuvastatin Calcium Tablets Recalled Nationwide Due to Manufacturing Deviations
Glenmark Pharmaceuticals is voluntarily recalling Rosuvastatin Calcium 40mg tablets nationwide due to manufacturing practice deviations. The recall affects specific lot numbers expiring February through June 2026.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries and a voluntary, firm-initiated precautionary recall based on identified CGMP deviations. The specific nature of the manufacturing deviation is not disclosed in the source material.
Plain-English summary
Glenmark Pharmaceuticals Inc. is voluntarily recalling Rosuvastatin Calcium 40mg tablets nationwide due to Current Good Manufacturing Practice (CGMP) deviations identified in their manufacturing process. The recall involves specific lot numbers with expiration dates from February through June 2026, supplied in 30-count bottles (NDC# 68462-264-30). The product was manufactured by Glenmark Pharmaceuticals Limited in Pithampur, India, for Glenmark Pharmaceuticals Inc. in Mahwah, New Jersey.
The recall was initiated by the firm on March 13, 2025, and classified as FDA Class II on April 8, 2025. No illnesses or injuries have been reported in connection with this recall.
The affected product was distributed nationwide throughout the United States. Consumers and healthcare providers who have dispensed or received this medication should consult with their pharmacy or healthcare provider regarding their rosuvastatin therapy.
The recalled product
- Product
- ROSUVASTATIN CALCIUM (ROSUVASTATIN CALCIUM)
- Brand
- ROSUVASTATIN CALCIUM
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Category
- Drug
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- Lot # 17240389
- exp. date Feb-26 17240390
- exp. date Feb-26 17240426
- exp. date Feb-26 17240427
- exp. date Feb-26 17240428
- exp. date Feb-26 17240778
- exp. date Apr-26 17241055
- exp. date May-26 17241074
- exp. date Jun-26 17241075
- exp. date Jun-26 17241091
- exp. date Jun-26 17241100
- exp. date Jun-26
UPCs (4)
- 0368462263907
- 0368462261903
- 0368462262900
- 0368462264300
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 39 recalled by Glenmark Pharmaceuticals Inc., USA under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 39 products in this recall →Related recalls
Same brand · ROSUVASTATIN CALCIUM
- ModerateRosuvastatin Calcium Tablets Recalled for Manufacturing Deviations
FDA (Drugs) · 2023-04-12
Same manufacturer · Glenmark Pharmaceuticals Inc., USA
See all →- ModerateAzelaic Acid Gel 15% Recalled Over Grainy, Gritty, or Sandy Texture
FDA (Drugs) · 2026-08-05
- ModerateAlyacen 7/7/7 birth control tablets failed total impurities specification
FDA (Drugs) · 2026-06-24
- ModerateOndansetron tablets recalled because blister packs are not fully sealed
FDA (Drugs) · 2026-01-07
- CriticalFrozen chopped methi recalled after testing positive for Salmonella
FDA (Drugs) · 2025-12-17
- ModerateBisoprolol and hydrochlorothiazide tablets recalled over traces of another drug
FDA (Drugs) · 2025-12-10
Same hazard · manufacturing defect
See all →- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-09-09
- HighSun Pharmaceutical Recalls Carbamazepine Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2026-08-26
- HighKnee Prosthesis Trial Recall for Manufacturing Defect
FDA (Devices) · 2026-08-12
- HighUSTAR II Knee System Hinge Box Trial Recall
FDA (Devices) · 2026-08-12
- HighU2 Total Knee System Femoral Valgus Adaptor Recall
FDA (Devices) · 2026-08-12